180 related articles for article (PubMed ID: 30726099)
1. Immuno-PET Imaging and Pharmacokinetics of an Anti-CEA scFv-based Trimerbody and Its Monomeric Counterpart in Human Gastric Carcinoma-Bearing Mice.
Rios X; Compte M; Gómez-Vallejo V; Cossío U; Baz Z; Morcillo MÁ; Ramos-Cabrer P; Alvarez-Vallina L; Llop J
Mol Pharm; 2019 Mar; 16(3):1025-1035. PubMed ID: 30726099
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
[TBL] [Abstract][Full Text] [Related]
3. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
[TBL] [Abstract][Full Text] [Related]
4. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
5. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
6. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
[TBL] [Abstract][Full Text] [Related]
7. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Kenanova V; Olafsen T; Crow DM; Sundaresan G; Subbarayan M; Carter NH; Ikle DN; Yazaki PJ; Chatziioannou AF; Gambhir SS; Williams LE; Shively JE; Colcher D; Raubitschek AA; Wu AM
Cancer Res; 2005 Jan; 65(2):622-31. PubMed ID: 15695407
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
Yazaki PJ; Kassa T; Cheung CW; Crow DM; Sherman MA; Bading JR; Anderson AL; Colcher D; Raubitschek A
Nucl Med Biol; 2008 Feb; 35(2):151-8. PubMed ID: 18312824
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
Kenanova V; Olafsen T; Williams LE; Ruel NH; Longmate J; Yazaki PJ; Shively JE; Colcher D; Raubitschek AA; Wu AM
Cancer Res; 2007 Jan; 67(2):718-26. PubMed ID: 17234783
[TBL] [Abstract][Full Text] [Related]
10. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific accumulation of 125I-labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autoradiography and immunostaining.
Haruno M; Kuroki M; Matsunaga K; Takata J; Karube Y; Senba T; Murakami M; Arakawa F; Kuwahara M; Ozaki H; Matsuoka Y; Okazaki M; Kanda H
Nucl Med Biol; 1996 Aug; 23(6):821-6. PubMed ID: 8940726
[TBL] [Abstract][Full Text] [Related]
12. Immuno-PET Imaging of
Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
[TBL] [Abstract][Full Text] [Related]
13. A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts.
Rochefort MM; Girgis MD; Knowles SM; Ankeny JS; Salazar F; Wu AM; Tomlinson JS
Mol Imaging Biol; 2014 Oct; 16(5):721-9. PubMed ID: 24691872
[TBL] [Abstract][Full Text] [Related]
14. Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.
Lütje S; Franssen GM; Sharkey RM; Laverman P; Rossi EA; Goldenberg DM; Oyen WJ; Boerman OC; McBride WJ
Bioconjug Chem; 2014 Feb; 25(2):335-41. PubMed ID: 24382090
[TBL] [Abstract][Full Text] [Related]
15. Efficient targeting of gastric cancer cells using radiolabeled anti-carcinoembryonic antigen-specific T84.66 fragments in experimental radioimmunoguided surgery.
Kim JC; Hong HK; Roh SA; Koo KH; Ka IH; Namgung H; Lee KH; Ryu JH; Yu CS; Oh SJ; Ryu JS; Kim JS; Kim HC
Anticancer Res; 2004; 24(2B):663-70. PubMed ID: 15161009
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.
Schoffelen R; Sharkey RM; Goldenberg DM; Franssen G; McBride WJ; Rossi EA; Chang CH; Laverman P; Disselhorst JA; Eek A; van der Graaf WT; Oyen WJ; Boerman OC
Mol Cancer Ther; 2010 Apr; 9(4):1019-27. PubMed ID: 20354120
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies.
Mikkelsen K; Harwood SL; Compte M; Merino N; Mølgaard K; Lykkemark S; Alvarez-Mendez A; Blanco FJ; Álvarez-Vallina L
Front Immunol; 2019; 10():1791. PubMed ID: 31417564
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.
Karube Y; Katsuno K; Takata J; Matsunaga K; Haruno M; Kuroki M; Arakawa F; Matsuoka Y; Kanda H
Nucl Med Biol; 1996 Aug; 23(6):753-9. PubMed ID: 8940717
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
